Natera, Inc. (NTRA) stock
NTRANasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 10/30138% above fair value
$287.47−1.01 (-0.35%)
Close on Nov 17, 2026Market cap $41.44BP/E –Yield –
Natera total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Natera's total debt was $80.29M at Jun 30, 2026. For fiscal 2025 it was $80.32M, down 0.0% from the year before. Over ten years it grew 6.7% a year on average. The highest annual figure on record is $80.40M in fiscal 2023.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.32M | -0.0% |
| FY2024 | Dec 31, 2024 | $80.36M | -0.0% |
| FY2023 | Dec 31, 2023 | $80.40M | +0.1% |
| FY2022 | Dec 31, 2022 | $80.35M | +60.5% |
| FY2021 | Dec 31, 2021 | $50.05M | -0.0% |
| FY2020 | Dec 31, 2020 | $50.05M | -0.1% |
| FY2019 | Dec 31, 2019 | $50.12M | -0.1% |
| FY2018 | Dec 31, 2018 | $50.15M | +0.1% |
| FY2017 | Dec 31, 2017 | $50.11M | +1.0% |
| FY2016 | Dec 31, 2016 | $49.62M | +17.9% |
| FY2015 | Dec 31, 2015 | $42.09M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $80.29M | -0.1% |
| Q1 FY2026 | Mar 31, 2026 | $80.31M | -0.0% |
| Q4 FY2025 | Dec 31, 2025 | $80.32M | -0.0% |
| Q3 FY2025 | Sep 30, 2025 | $80.34M | -0.2% |
| Q2 FY2025 | Jun 30, 2025 | $80.34M | -0.1% |
| Q1 FY2025 | Mar 31, 2025 | $80.35M | -0.1% |
| Q4 FY2024 | Dec 31, 2024 | $80.36M | -0.0% |
| Q3 FY2024 | Sep 30, 2024 | $80.47M | +0.0% |
| Q2 FY2024 | Jun 30, 2024 | $80.39M | -0.0% |
| Q1 FY2024 | Mar 31, 2024 | $80.40M | +0.0% |
| Q4 FY2023 | Dec 31, 2023 | $80.40M | +0.1% |
| Q3 FY2023 | Sep 30, 2023 | $80.44M | +60.4% |
| Q2 FY2023 | Jun 30, 2023 | $80.42M | +60.6% |
| Q1 FY2023 | Mar 31, 2023 | $80.40M | +60.6% |
| Q4 FY2022 | Dec 31, 2022 | $80.35M | +60.5% |
| Q3 FY2022 | Sep 30, 2022 | $50.15M | +0.2% |
| Q2 FY2022 | Jun 30, 2022 | $50.09M | +0.1% |
| Q1 FY2022 | Mar 31, 2022 | $50.06M | +0.0% |
| Q4 FY2021 | Dec 31, 2021 | $50.05M | -0.0% |
| Q3 FY2021 | Sep 30, 2021 | $50.05M | -0.0% |
| Q2 FY2021 | Jun 30, 2021 | $50.05M | -0.0% |
| Q1 FY2021 | Mar 31, 2021 | $50.05M | -0.1% |
| Q4 FY2020 | Dec 31, 2020 | $50.05M | -0.1% |
| Q3 FY2020 | Sep 30, 2020 | $50.05M | -0.2% |
| Q2 FY2020 | Jun 30, 2020 | $50.05M | -0.2% |
| Q1 FY2020 | Mar 31, 2020 | $50.09M | -0.1% |
| Q4 FY2019 | Dec 31, 2019 | $50.12M | -0.1% |
| Q3 FY2019 | Sep 30, 2019 | $50.13M | -0.0% |
| Q2 FY2019 | Jun 30, 2019 | $50.15M | +0.0% |
| Q1 FY2019 | Mar 31, 2019 | $50.15M | +0.1% |
| Q4 FY2018 | Dec 31, 2018 | $50.15M | +0.1% |
| Q3 FY2018 | Sep 30, 2018 | $50.14M | +0.1% |
| Q2 FY2018 | Jun 30, 2018 | $50.13M | +0.2% |
| Q1 FY2018 | Mar 31, 2018 | $50.13M | +0.6% |
| Q4 FY2017 | Dec 31, 2017 | $50.11M | +1.0% |
| Q3 FY2017 | Sep 30, 2017 | $50.10M | +1.3% |
| Q2 FY2017 | Jun 30, 2017 | $50.02M | – |
| Q1 FY2017 | Mar 31, 2017 | $49.81M | – |
| Q4 FY2016 | Dec 31, 2016 | $49.62M | – |
| Q3 FY2016 | Sep 30, 2016 | $49.47M | – |
See a number that looks wrong?